首页|地屈孕酮联合黄体酮对先兆流产保胎成功情况、激素水平、新生儿出生指标、疗效及安全性的影响研究

地屈孕酮联合黄体酮对先兆流产保胎成功情况、激素水平、新生儿出生指标、疗效及安全性的影响研究

扫码查看
目的 探究先兆流产患者联合应用地屈孕酮、黄体酮治疗对保胎成功情况、激素水平、新生儿出生指标、疗效及安全性的影响.方法 100 例先兆流产患者,经随机数字表法分为对照组与观察组,每组 50 例.对照组实施地屈孕酮治疗,观察组实施地屈孕酮联合黄体酮治疗.比较两组保胎成功情况、激素[雌二醇(E2)、孕酮(P)、人绒毛膜促性腺激素(HCG)]水平、新生儿指标(新生儿体重和新生儿畸形率)、治疗效果以及不良反应发生情况.结果 观察组保胎成功率为 88.00%,高于对照组的 70.00%,差异显著(P<0.05).治疗后,两组E2、P、HCG水平均上升,且观察组E2、P、HCG水平分别为(1078.41±18.26)pg/ml、(31.86±3.66)nmol/L、(8574.21±96.69)U/ml,高于对照组的(905.25±26.69)pg/ml、(25.91±4.13)nmol/L、(7410.33±105.53)U/ml,差异显著(P<0.05).对照组新生儿体重为(3259.87±84.91)g,新生儿畸形 0 例;观察组新生儿体重为(3275.46±86.29)g,新生儿畸形 1 例(2.00%).两组新生儿体重、新生儿畸形率比较无显著差异(P>0.05).观察组治疗总有效率 96.00%高于对照组的84.00%,差异显著(P<0.05).两组不良反应发生率比较,无显著差异(P>0.05).结论 先兆流产患者联合应用地屈孕酮、黄体酮治疗可获得突出效果,利于提升先兆流产保胎成功率,改善激素水平,不会对新生儿出生指标产生影响,且安全性较高,建议临床推广应用.
Study on the effect of dydrogesterone combined with progesterone on the success of fetal preservation,hormone level,neonatal birth index and curative effect and safety of threatened abortion
Objective To explore the effect of dydrogesterone combined with progesterone on the success of fetal preservation,hormone level,neonatal birth index and curative effect and safety of threatened abortion.Methods A total of 100 patients with threatened abortion were divided into a control group and an observation group by random number table,with 50 cases in each group.The control group was treated with dydrogesterone,and the observation group was treated with dydrogesterone and progesterone.The success of fetal preservation,hormone[estradiol(E2),progesterone(P),human chorionic gonadotropin(HCG)]level,neonatal index(neonatal weight,neonatal malformation rate),the treatment effect and the occurrence of adverse reactions were compared between the two groups.Results The success rates of fetal preservation in the observation group was 88.00%,which was higher than 70.00%in the control group,with a significant difference(P<0.05).After treatment,the E2,P and HCG levels increased in both groups,and E2,P and HCG levels in the observation group were(1078.41±18.26)pg/ml,(31.86±3.66)nmol/L and(8574.21±96.69)U/ml,which were higher than(905.25±26.69)pg/ml,(25.91±4.13)nmol/L and(7410.33±105.53)U/ml in the control group.The difference was significant(P<0.05).The neonatal weight in the control group was(3259.87±84.91)g,with 0 case of neonatal malformations;the neonatal weight in the observation group was(3275.46±86.29)g,with 1 case(2.00%)of neonatal malformation.There was no significant difference in neonatal weight and neonatal malformation rate between the two groups(P>0.05).The total effective rate of 96.00%in the observation group was higher than 84.00%in the control group,with a significant difference(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of dydrogesterone and progesterone in the treatment of threatened abortion patients can achieve prominent effect,which is beneficial to improve the success rate of fetal preservation,improve the level of various hormones,and will not affect the neonatal birth index,and has high safety.It is recommended to be widely used in clinical practice.

DydrogesteroneProgesteroneThreatened abortionSuccess of fetal preservationHormone levelNeonatal birth index

杜鲁豫、陈怀博

展开 >

252000 聊城市妇幼保健院妇产科

252300 阳谷县疾病预防控制中心检验科

地屈孕酮 黄体酮 先兆流产 保胎成功情况 激素水平 新生儿出生指标

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(3)
  • 20